High-throughput nanoparticle synthesis combined with machine learning speeds up the exploration of structure–activity relationships for nanomedicines, as shown for spherical nucleic acids functioning as cancer-vaccine candidates.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Liu, Z. et al. Nano Lett. 18, 6655–6659 (2018).
Irvine, D. Nat. Mat. 17, 472–473 (2018).
Zhu, G. et al. ACS Nano 11, 2387–2392 (2017).
Urbanavicius, D. et al. Mol. Immunol. 98, 2–7 (2018).
Björnmalm, M. et al. ACS Nano 11, 9594–9613 (2017).
Radovic-Moreno, A. F. et al. Proc. Natl Acad. Sci. USA 112, 3892–3897 (2015).
Yamankurt, G. et al. N. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0351-1 (2019).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y., Chen, X. Efficient screening of spherical nucleic acids. Nat Biomed Eng 3, 257–258 (2019). https://doi.org/10.1038/s41551-019-0391-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-019-0391-6